XIAOMI-W
01810
POP MART
09992
BABA-W
09988
4
MEITUAN-W
03690
5
ICBC
01398
HK Stock MarketDetailed Quotes
00314 SIPAI HEALTH
- 4.390
- +0.040+0.92%
Market Closed Apr 30 16:08 CST
3.32BMarket Cap-9.48P/E (TTM)
4.410High4.330Low1.42MVolume4.340Open4.350Pre Close6.21MTurnover0.19%Turnover RatioLossP/E (Static)755.54MShares7.38052wk High2.51P/B3.32BFloat Cap4.07052wk Low--Dividend TTM755.54MShs Float44.600Historical High--Dividend LFY1.84%Amplitude4.070Historical Low4.372Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
SIPAI HEALTH Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -3.11%4.57B | -3.04%2.36B | 14.39%4.71B | 29.15%2.44B | 18.58%4.12B | 21.78%1.89B | 28.68%3.47B | --1.55B | 64.67%765.39M | 159.83%2.7B |
| Operating income | -3.11%4.57B | -3.04%2.36B | 14.39%4.71B | 29.15%2.44B | 18.58%4.12B | 21.78%1.89B | 28.68%3.47B | 1.55B | 64.67%765.39M | 159.83%2.7B |
| Cost of sales | 2.76%-4.18B | 3.83%-2.13B | -13.62%-4.3B | -29.76%-2.22B | -18.54%-3.78B | -19.50%-1.71B | -26.97%-3.19B | ---1.43B | -58.79%-713.7M | -162.51%-2.51B |
| Operating expenses | 2.76%-4.18B | 3.83%-2.13B | -13.62%-4.3B | -29.76%-2.22B | -18.54%-3.78B | -19.50%-1.71B | -26.97%-3.19B | -1.43B | -58.79%-713.7M | -162.51%-2.51B |
| Gross profit | -6.82%386.43M | 4.97%228.93M | 22.93%414.7M | 23.25%218.09M | 19.02%337.35M | 49.34%176.94M | 51.69%283.45M | 118.48M | 236.88%51.69M | 128.42%186.86M |
| Selling expenses | 4.78%-278.35M | 9.36%-137.82M | 12.18%-292.32M | 5.33%-152.05M | -14.20%-332.85M | -15.33%-160.61M | -58.88%-291.46M | ---139.27M | -97.40%-66.1M | -58.10%-183.45M |
| Administrative expenses | 6.85%-323.97M | 7.69%-161.89M | 39.52%-347.79M | 30.50%-175.38M | 14.18%-575.01M | 19.01%-252.33M | -85.48%-670.02M | ---311.54M | -87.21%-129.82M | -64.60%-361.24M |
| Research and development expenses | 51.55%-22.26M | 37.09%-15.01M | 26.66%-45.95M | 30.40%-23.86M | -5.82%-62.65M | -17.00%-34.29M | -29.43%-59.21M | ---29.31M | -37.13%-13.06M | -84.08%-45.74M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,108.28%-1.42B | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,108.28%-1.42B | ---- |
| Impairment and provision | -254.23%-35.3M | -79.93%-3.29M | -82.31%-9.97M | 63.44%-1.83M | 14.69%-5.47M | -81.60%-5M | -20.18%-6.41M | ---2.76M | 15.36%-1.97M | -188.94%-5.33M |
| -Other impairment is provision | -254.23%-35.3M | -79.93%-3.29M | -82.31%-9.97M | 63.44%-1.83M | 14.69%-5.47M | -81.60%-5M | -20.18%-6.41M | ---2.76M | 15.36%-1.97M | -188.94%-5.33M |
| Operating interest expense | 12.04%-3.07M | ---- | 13.66%-3.49M | ---- | -9.57%-4.04M | -4.10%-1.96M | -4.56%-3.69M | ---1.88M | -4.66%-943K | -22.59%-3.53M |
| Special items of operating profit | -312.20%-83.94M | -68.84%15.63M | -19.52%39.56M | 181.42%50.16M | 2.52%49.15M | -0.22%17.82M | 65.38%47.95M | --17.86M | 638.93%8.41M | 329.64%28.99M |
| Operating profit | -46.97%-360.45M | 13.46%-73.45M | 58.68%-245.25M | 67.28%-84.87M | 15.14%-593.51M | 25.54%-259.42M | -82.40%-699.39M | -348.4M | -625.73%-1.57B | -38.67%-383.44M |
| Financing cost | ---- | 14.97%-1.55M | ---- | ---1.82M | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | 54.61%-187K | ---157K | -224.47%-412K | ---- | 141.61%331K | 123.68%81K | 310.77%137K | ---342K | -3,916.67%-229K | -111.09%-65K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | 74.57%-775.26M | 96.07%-85.1M | -363.75%-3.05B | ---2.17B | ---- | -105.36%-657.34M |
| Earning before tax | -46.80%-360.64M | 13.31%-75.16M | 82.05%-245.67M | 74.83%-86.7M | 63.49%-1.37B | 86.31%-344.44M | -260.06%-3.75B | -2.52B | -625.85%-1.57B | -74.63%-1.04B |
| Tax | -14.41%-1.19M | 183.42%508K | 68.66%-1.04M | 60.61%-609K | -302.67%-3.32M | -4,168.42%-1.55M | 30.03%-825K | --38K | 121.62%32K | -2,211.76%-1.18M |
| After-tax profit from continuing operations | -46.66%-361.83M | 14.50%-74.65M | 82.02%-246.71M | 74.77%-87.31M | 63.41%-1.37B | 86.25%-345.99M | -259.73%-3.75B | -2.52B | -625.34%-1.57B | -74.82%-1.04B |
| Earning after tax | -46.66%-361.83M | 14.50%-74.65M | 82.02%-246.71M | 74.77%-87.31M | 63.41%-1.37B | 86.25%-345.99M | -259.73%-3.75B | -2.52B | -625.34%-1.57B | -74.82%-1.04B |
| Minority profit | -520.44%-38.1M | -29.18%3.55M | 860.15%9.06M | 1,374.71%5.01M | 85.19%-1.19M | 105.07%340K | -1,170.21%-8.05M | ---6.71M | -800.28%-2.54M | 150.95%752K |
| Profit attributable to shareholders | -26.57%-323.74M | 15.29%-78.2M | 81.34%-255.77M | 73.34%-92.32M | 63.36%-1.37B | 86.20%-346.33M | -258.70%-3.74B | -2.51B | -622.97%-1.57B | -75.38%-1.04B |
| Basic earnings per share | -27.50%-0.51 | 14.29%-0.12 | 96.72%-0.4 | 96.00%-0.14 | 67.59%-12.19 | 86.07%-3.5 | -260.59%-37.61 | -25.12 | -623.50%-15.7 | -75.29%-10.43 |
| Diluted earnings per share | -27.50%-0.51 | 14.29%-0.12 | 96.72%-0.4 | 96.00%-0.14 | 67.59%-12.19 | 86.07%-3.5 | -260.59%-37.61 | -25.12 | -623.50%-15.7 | -75.29%-10.43 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.